Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;4(4):e217943.
doi: 10.1001/jamanetworkopen.2021.7943.

Public Perspectives on COVID-19 Vaccine Prioritization

Affiliations

Public Perspectives on COVID-19 Vaccine Prioritization

Govind Persad et al. JAMA Netw Open. .

Abstract

Importance: As COVID-19 vaccine distribution continues, policy makers are struggling to decide which groups should be prioritized for vaccination.

Objective: To assess US adults' preferences regarding COVID-19 vaccine prioritization.

Design, setting, and participants: This survey study involved 2 independent, online surveys of US adults aged 18 years and older, 1 conducted by Gallup from September 14 to 27, 2020, and the other conducted by the COVID Collaborative from September 19 to 25, 2020. Samples were weighted to reflect sociodemographic characteristics of the US population.

Exposures: Respondents were asked to prioritize groups for COVID-19 vaccine and to rank their prioritization considerations.

Main outcomes and measures: The study assessed prioritization preferences and agreement with the National Academies of Science, Engineering, and Medicine's Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.

Results: A total of 4735 individuals participated, 2730 (1474 men [54.1%]; mean [SD] age, 59.2 [14.5] years) in the Gallup survey and 2005 (944 men [47.1%]; 203 participants [21.5%] aged 55-59 years) in the COVID Collaborative survey. In both the Gallup COVID-19 Panel and COVID Collaborative surveys, respondents listed health care workers (Gallup, 93.6% [95% CI, 91.2%-95.3%]; COVID Collaborative, 80.0% [95% CI, 78.0%-81.9%]) and adults of any age with serious comorbid conditions (Gallup, 78.6% [95% CI, 75.2%-81.7%]; COVID Collaborative, 72.9% [95% CI, 70.7%-74.9%]) among their 4 highest priority groups. Respondents of all political affiliations agreed with prioritizing Black, Hispanic, Native American, and other communities that have been disproportionately affected by COVID-19 (Gallup, 74.2% [95% CI, 70.6%-77.5%]; COVID Collaborative, 84.9% [95% CI, 83.1%-86.5%]), and COVID Collaborative respondents were willing to be preceded in line by teachers and childcare workers (92.5%; 95% CI, 91.2%-93.7%) and grocery workers (85.9%; 95% CI, 84.2%-87.5%). Older respondents in both surveys were significantly less likely than younger respondents to prioritize healthy adults aged 65 years and older among their 4 highest priority groups (Gallup, 23.7% vs 39.1% [χ2 = 2160.8; P < .001]; COVID Collaborative, 23.3% vs 28.8% [χ2 = 5.0198; P = .03]). COVID Collaborative respondents believed the 4 most important considerations for prioritization were preventing COVID-19 spread (78.4% [95% CI, 76.3%-80.3%]), preventing the most deaths (72.1% [95% CI, 69.9%-74.2%]), preventing long-term complications (68.9% [66.6%-71.9%]), and protecting frontline workers (63.8% [95% CI, 61.5%-66.1%]).

Conclusions and relevance: US adults broadly agreed with the National Academies of Science, Engineering, and Medicine's prioritization framework. Respondents endorsed prioritizing racial/ethnic communities that are disproportionately affected by COVID-19, and older respondents were significantly less likely than younger respondents to endorse prioritizing healthy people older than 65 years. This provides reason for caution about COVID-19 vaccine distribution plans that prioritize healthy adults older than a cutoff age without including those younger than that age with preexisting conditions, that aim solely to prevent the most deaths, or that give no priority to frontline workers or disproportionately affected communities.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Persad reported receiving grants from Greenwall Foundation and personal fees from ASCO Post and the World Health Organization outside the submitted work. Dr Emanuel reported being a partner at ReCovery Partners, LLC, Oak HC/FT, and Embedded Healthcare, LLC; receiving personal fees from Center for Neurodegenerative Disease Research, Genentech Oncology, Council of Insurance Agents and Brokers, America’s Health Insurance Plans, Montefiore Physician Leadership Academy, Greenwall Foundation, Medical Home Network, Healthcare Financial Management Association, Ecumenical Center–UT Health, American Academy of Optometry, Associação Nacional de Hospitais Privados, National Alliance of Healthcare Purchaser Coalitions, Optum Labs, Massachusetts Association of Health Plans, District of Columbia Hospital Association, Washington University, Brown University, McKay Lab, American Society for Surgery of the Hand, Association of American Medical Colleges, America’s Essential Hospitals, Johns Hopkins University, National Resident Matching Program, Shore Memorial Health System, Tulane University, Oregon Health & Science University, United Health Group, CBI, and Blue Cross Blue Shield; and receiving nonfinancial support (travel reimbursement) from the Center for Global Development, The Atlantic, RAND Corporation, and Goldman Sachs outside the submitted work. Dr Glickman reported receiving a gift from the Colton Foundation during the conduct of the study. Dr Largent reported receiving grants from the National Institute on Aging and the Greenwall Foundation outside the submitted work. No other disclosures were reported.

Similar articles

Cited by

References

    1. US Food and Drug Administration . FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. Published December 11, 2020. Accessed March 11, 2021. https://www.fda.gov/news-events/press-announcements/fda-takes-key-action...
    1. Gayle H, Foege W, Brown L, Kahn B. Framework for Equitable Allocation of COVID-19 Vaccine. National Academies Press, 2020. doi:10.17226/25917 - DOI - PubMed
    1. Dooling K, McClung N, Chamberland M, et al. . The Advisory Committee on Immunization Practices’ interim recommendation for allocating initial supplies of COVID-19 vaccine—United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(49):1857-1859. doi:10.15585/mmwr.mm6949e1 - DOI - PMC - PubMed
    1. Branswell H. Adults over 75, frontline essential workers should be in second Covid-19 vaccine priority group, says CDC advisory panel. STAT. Published December 20, 2020. Accessed March 11, 2021. https://www.statnews.com/2020/12/20/adults-over-75-frontline-essential-w...
    1. Dooling K, Marin M, Wallace M, et al. . The Advisory Committee on Immunization Practices’ updated interim recommendation for allocation of COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1657-1660. doi:10.15585/mmwr.mm695152e2 - DOI - PMC - PubMed

Publication types

Substances